Patent · US Active

Interleukin-13 binding cyclic oligopeptides and methods of use thereof

US12180307B2 · kind B2 · utility

0Cited by

10References

10Claims

0Family size

Assignee

B.A.I. Laboratories, LLC · US

Inventors

Xuefei Bai · Beijing, CN
Sheng Lin · Beijing, CN
Le Li · Hangzhou City, CN

Key dates

Filing date	Jun 13, 2023
Grant date	Dec 31, 2024
Priority date	—
Expiry date	Jun 13, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to cyclic oligopeptides that bind to interleukin-13 (IL-13) which are useful therapeutically in methods of treating or preventing IL-13-associated skin disorders or conditions. The present disclosure also provides methods to treat or prevent IL-13-associated skin disorders or conditions with the IL-13-binding cyclic oligopeptides. The present disclosure further provides methods to produce the IL-13-binding cyclic oligopeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.